The Coma Family Program (COMA-F): A Resilience Program for Caregivers of Patients With Severe Acute Brain Injury
COMA-F
1 other identifier
interventional
150
1 country
3
Brief Summary
The purpose of this research study is to determine whether COMA-F is more efficacious at reducing emotional distress in caregivers of patients with severe acute brain injuries, compared to health education control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
February 20, 2026
February 1, 2026
4.3 years
December 16, 2025
February 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital anxiety and depression scale
Measures anxiety and depression. Anxiety and depression sub scales each range from 0 (minimum) to 21 (maximum) with higher scores meaning worse outcome.
baseline, 6-weeks, and 3-month follow-up
Secondary Outcomes (2)
Posttraumatic stress disorder checklist-5
baseline, 6-weeks, and 3-month follow-up
World Health Organization Quality of Life-Short Form
baseline, 6-weeks, and 3-month follow-up
Other Outcomes (5)
Cognitive and Affective Mindfulness Scale
baseline, 6-weeks, and 3-month follow-up
Applied Mindfulness Process Scale
baseline, 6-weeks, and 3-month follow-up
Measure of Current Status-A
baseline, 6-weeks, and 3-month follow-up
- +2 more other outcomes
Study Arms (2)
Coma Family Program 1
EXPERIMENTALThis arm provides skills training to manage distress, uncertainty, and long-term caregiving challenges.
Coma Family Program 2
PLACEBO COMPARATORThis arm involves providing education about managing caregiving distress, uncertainty, and long-term challenges.
Interventions
This intervention provides skills training to manage distress, uncertainty, and long-term caregiving challenges.
This involves education (but no skills training) about managing caregiving distress, uncertainty, and long-term challenges.
Eligibility Criteria
You may qualify if:
- years or older - study population
- English fluency and literacy - measures and intervention are in English
- Screens positive for emotional distress on either depression or anxiety subscales (\>7) of the Hospital Anxiety and Depression scale - study population (caregivers must be at-risk for chronic distress via heightened acute distress)
- Confirmed by the clinical team as the primary caregiver of a patient who has been admitted to an intensive care unit (ICU) with a severe acute brain injury with the following characteristics:
- years or older - study population
- Admitted with ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, traumatic brain injury, or hypoxic-ischemic encephalopathy - study population
- Glasgow Coma Scale score below 9 (in judgement of the clinical team) while not intubated or an inability to follow meaningful commands while intubated at any point during the hospitalization for \> 24 consecutive hours due to the brain injury itself and not a confounding factor (e.g., sedation or seizures) - study population
- Still alive in ICU at the time the clinical team approaches the caregiver about possible recruitment - excludes caregivers of those that passed away as would require a different intervention (e.g., grieving intervention)
- Has been committed to or has already received long-term life-sustaining treatments including tracheostomy and/or percutaneous endoscopic or surgical gastrostomy tube placement (trach or PEG) - study population; at time of enrollment patients can be in various early stages of cognitive/functional recovery from initial coma, but all were severe enough to require trach and/or PEG
- Has a prognosis for survival of greater than 3 months and does not have a concurrent diagnosis of a terminal illness or injury as judged by the clinical team - as in "d"; such caregivers would require different intervention
- Is still in ICU or has been transferred to a lower level of care (e.g., stepdown) for \<7 days at the time of consent - study population; we aim to begin the intervention when caregivers are acutely distressed in the context of the patient's ICU stay or shortly after the ICU stay (i.e., within 7 days of leaving)
You may not qualify if:
- \. Serious mental illness, substance misuse, or active suicidal intent or plan - requires higher level of care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
University of Maryland School of Medicine
Baltimore, Maryland, 21201, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
University of North Carolina School of Medicine
Chapel Hill, North Carolina, 27599, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Member of the Faculty
Study Record Dates
First Submitted
December 16, 2025
First Posted
January 9, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
August 1, 2030
Study Completion (Estimated)
December 1, 2030
Last Updated
February 20, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- All de-identified data will be preserved for at least seven years after closing the study with IRB.
- Access Criteria
- The de-identified quantitative dataset will be made freely available for requests that are ethically sound.
Data includes caregiver demographic characteristics, health characteristics (quality of life), and outcome assessments (e.g., emotional distress, coping, mindfulness, etc). These measures will be self-reported. We will also collect limited quantitative data extracted from patients' medical charts (diagnosis, age, race, ethnicity). All data will be de-identified and preserved for at least seven years after closing the study with IRB. Quantitative datasets will be made available via the Vivli database.